5-lipoxygenase-activating protein (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "5-lipoxygenase-activating protein" in English language version.

refsWebsite

Global rank English rank

13nih.gov

4^th place

10doi.org

2^nd place

3worldcat.org

5^th place

2semanticscholar.org

11^th place

8^th place

1ensembl.org

1,626^th place

1,007^th place

1rcsb.org

8,838^th place

8,783^rd place

1harvard.edu

18^th place

17^th place

doi.org

Kennedy BP, Diehl RE, Boie Y, Adam M, Dixon RA (May 1991). "Gene characterization and promoter analysis of the human 5-lipoxygenase-activating protein (FLAP)". The Journal of Biological Chemistry. 266 (13): 8511–6. doi:10.1016/S0021-9258(18)93004-8. PMID 1673682.
Yandava CN, Kennedy BP, Pillari A, Duncan AM, Drazen JM (February 1999). "Cytogenetic and radiation hybrid mapping of human arachidonate 5-lipoxygenase-activating protein (ALOX5AP) to chromosome 13q12". Genomics. 56 (1): 131–3. doi:10.1006/geno.1998.5651. PMID 10036194.
Peters-Golden M, Brock TG (2003). "5-lipoxygenase and FLAP". Prostaglandins, Leukotrienes, and Essential Fatty Acids. 69 (2–3): 99–109. doi:10.1016/S0952-3278(03)00070-X. PMID 12895592.
Serhan CN, Chiang N, Dalli J, Levy BD (2015). "Lipid mediators in the resolution of inflammation". Cold Spring Harbor Perspectives in Biology. 7 (2): a016311. doi:10.1101/cshperspect.a016311. PMC 4315926. PMID 25359497.
PDB: 2q7r;Ferguson AD, McKeever BM, Xu S, Wisniewski D, Miller DK, Yamin TT, Spencer RH, Chu L, Ujjainwalla F, Cunningham BR, Evans JF, Becker JW (July 2007). "Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein". Science. 317 (5837): 510–2. Bibcode:2007Sci...317..510F. doi:10.1126/science.1144346. PMID 17600184. S2CID 31544959.
Kaushal, Ritesh; Pal, Prodipto; Alwell, Kathleen; Haverbusch, Mary; Flaherty, Matthew; Moomaw, Charles; Sekar, Padmini; Kissela, Brett; Kleindorfer, Dawn; Chakraborty, Ranajit; Broderick, Joseph; Deka, Ranjan; Woo, Daniel (2007-06-01). "Association of ALOX5AP with ischemic stroke: a population-based case-control study". Human Genetics. 121 (5): 601–607. doi:10.1007/s00439-007-0338-y. ISSN 1432-1203. PMID 17387518. S2CID 20183625.
Evans, Jilly F.; Ferguson, Andrew D.; Mosley, Ralph T.; Hutchinson, John H. (February 2008). "What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases". Trends in Pharmacological Sciences. 29 (2): 72–78. doi:10.1016/j.tips.2007.11.006. ISSN 0165-6147. PMID 18187210.
Musiyenko A, Correa L, Stock N, Hutchinson JH, Lorrain DS, Bain G, Evans JF, Barik S (November 2009). "A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye". Clinical and Vaccine Immunology. 16 (11): 1654–9. doi:10.1128/CVI.00220-09. PMC 2772391. PMID 19759251.
Gillard, J.; Ford-Hutchinson, A. W.; Chan, C.; Charleson, S.; Denis, D.; Foster, A.; Fortin, R.; Leger, S.; McFarlane, C. S.; Morton, H.; Piechuta, H.; Riendeau, D.; Rouzer, C. A.; Rokach, J.; Young, R. (1989-05-01). "L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor". Canadian Journal of Physiology and Pharmacology. 67 (5): 456–464. doi:10.1139/y89-073. ISSN 0008-4212. PMID 2548691.

dx.doi.org

Gillard, J.; Ford-Hutchinson, A. W.; Chan, C.; Charleson, S.; Denis, D.; Foster, A.; Fortin, R.; Leger, S.; McFarlane, C. S.; Morton, H.; Piechuta, H.; Riendeau, D.; Rouzer, C. A.; Rokach, J.; Young, R. (1989-05-01). "L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor". Canadian Journal of Physiology and Pharmacology. 67 (5): 456–464. doi:10.1139/y89-073. ISSN 0008-4212. PMID 2548691.

ensembl.org

May2017.archive.ensembl.org

GRCm38: Ensembl release 89: ENSMUSG00000060063 – Ensembl, May 2017

harvard.edu

ui.adsabs.harvard.edu

PDB: 2q7r;Ferguson AD, McKeever BM, Xu S, Wisniewski D, Miller DK, Yamin TT, Spencer RH, Chu L, Ujjainwalla F, Cunningham BR, Evans JF, Becker JW (July 2007). "Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein". Science. 317 (5837): 510–2. Bibcode:2007Sci...317..510F. doi:10.1126/science.1144346. PMID 17600184. S2CID 31544959.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kennedy BP, Diehl RE, Boie Y, Adam M, Dixon RA (May 1991). "Gene characterization and promoter analysis of the human 5-lipoxygenase-activating protein (FLAP)". The Journal of Biological Chemistry. 266 (13): 8511–6. doi:10.1016/S0021-9258(18)93004-8. PMID 1673682.
Yandava CN, Kennedy BP, Pillari A, Duncan AM, Drazen JM (February 1999). "Cytogenetic and radiation hybrid mapping of human arachidonate 5-lipoxygenase-activating protein (ALOX5AP) to chromosome 13q12". Genomics. 56 (1): 131–3. doi:10.1006/geno.1998.5651. PMID 10036194.
Peters-Golden M, Brock TG (2003). "5-lipoxygenase and FLAP". Prostaglandins, Leukotrienes, and Essential Fatty Acids. 69 (2–3): 99–109. doi:10.1016/S0952-3278(03)00070-X. PMID 12895592.
Serhan CN, Chiang N, Dalli J, Levy BD (2015). "Lipid mediators in the resolution of inflammation". Cold Spring Harbor Perspectives in Biology. 7 (2): a016311. doi:10.1101/cshperspect.a016311. PMC 4315926. PMID 25359497.
PDB: 2q7r;Ferguson AD, McKeever BM, Xu S, Wisniewski D, Miller DK, Yamin TT, Spencer RH, Chu L, Ujjainwalla F, Cunningham BR, Evans JF, Becker JW (July 2007). "Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein". Science. 317 (5837): 510–2. Bibcode:2007Sci...317..510F. doi:10.1126/science.1144346. PMID 17600184. S2CID 31544959.
Kaushal, Ritesh; Pal, Prodipto; Alwell, Kathleen; Haverbusch, Mary; Flaherty, Matthew; Moomaw, Charles; Sekar, Padmini; Kissela, Brett; Kleindorfer, Dawn; Chakraborty, Ranajit; Broderick, Joseph; Deka, Ranjan; Woo, Daniel (2007-06-01). "Association of ALOX5AP with ischemic stroke: a population-based case-control study". Human Genetics. 121 (5): 601–607. doi:10.1007/s00439-007-0338-y. ISSN 1432-1203. PMID 17387518. S2CID 20183625.
Evans, Jilly F.; Ferguson, Andrew D.; Mosley, Ralph T.; Hutchinson, John H. (February 2008). "What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases". Trends in Pharmacological Sciences. 29 (2): 72–78. doi:10.1016/j.tips.2007.11.006. ISSN 0165-6147. PMID 18187210.
Musiyenko A, Correa L, Stock N, Hutchinson JH, Lorrain DS, Bain G, Evans JF, Barik S (November 2009). "A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye". Clinical and Vaccine Immunology. 16 (11): 1654–9. doi:10.1128/CVI.00220-09. PMC 2772391. PMID 19759251.
Gillard, J.; Ford-Hutchinson, A. W.; Chan, C.; Charleson, S.; Denis, D.; Foster, A.; Fortin, R.; Leger, S.; McFarlane, C. S.; Morton, H.; Piechuta, H.; Riendeau, D.; Rouzer, C. A.; Rokach, J.; Young, R. (1989-05-01). "L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor". Canadian Journal of Physiology and Pharmacology. 67 (5): 456–464. doi:10.1139/y89-073. ISSN 0008-4212. PMID 2548691.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Serhan CN, Chiang N, Dalli J, Levy BD (2015). "Lipid mediators in the resolution of inflammation". Cold Spring Harbor Perspectives in Biology. 7 (2): a016311. doi:10.1101/cshperspect.a016311. PMC 4315926. PMID 25359497.
Musiyenko A, Correa L, Stock N, Hutchinson JH, Lorrain DS, Bain G, Evans JF, Barik S (November 2009). "A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye". Clinical and Vaccine Immunology. 16 (11): 1654–9. doi:10.1128/CVI.00220-09. PMC 2772391. PMID 19759251.

rcsb.org

PDB: 2q7r;Ferguson AD, McKeever BM, Xu S, Wisniewski D, Miller DK, Yamin TT, Spencer RH, Chu L, Ujjainwalla F, Cunningham BR, Evans JF, Becker JW (July 2007). "Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein". Science. 317 (5837): 510–2. Bibcode:2007Sci...317..510F. doi:10.1126/science.1144346. PMID 17600184. S2CID 31544959.

semanticscholar.org

api.semanticscholar.org

PDB: 2q7r;Ferguson AD, McKeever BM, Xu S, Wisniewski D, Miller DK, Yamin TT, Spencer RH, Chu L, Ujjainwalla F, Cunningham BR, Evans JF, Becker JW (July 2007). "Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein". Science. 317 (5837): 510–2. Bibcode:2007Sci...317..510F. doi:10.1126/science.1144346. PMID 17600184. S2CID 31544959.
Kaushal, Ritesh; Pal, Prodipto; Alwell, Kathleen; Haverbusch, Mary; Flaherty, Matthew; Moomaw, Charles; Sekar, Padmini; Kissela, Brett; Kleindorfer, Dawn; Chakraborty, Ranajit; Broderick, Joseph; Deka, Ranjan; Woo, Daniel (2007-06-01). "Association of ALOX5AP with ischemic stroke: a population-based case-control study". Human Genetics. 121 (5): 601–607. doi:10.1007/s00439-007-0338-y. ISSN 1432-1203. PMID 17387518. S2CID 20183625.

worldcat.org

search.worldcat.org

Kaushal, Ritesh; Pal, Prodipto; Alwell, Kathleen; Haverbusch, Mary; Flaherty, Matthew; Moomaw, Charles; Sekar, Padmini; Kissela, Brett; Kleindorfer, Dawn; Chakraborty, Ranajit; Broderick, Joseph; Deka, Ranjan; Woo, Daniel (2007-06-01). "Association of ALOX5AP with ischemic stroke: a population-based case-control study". Human Genetics. 121 (5): 601–607. doi:10.1007/s00439-007-0338-y. ISSN 1432-1203. PMID 17387518. S2CID 20183625.
Evans, Jilly F.; Ferguson, Andrew D.; Mosley, Ralph T.; Hutchinson, John H. (February 2008). "What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases". Trends in Pharmacological Sciences. 29 (2): 72–78. doi:10.1016/j.tips.2007.11.006. ISSN 0165-6147. PMID 18187210.
Gillard, J.; Ford-Hutchinson, A. W.; Chan, C.; Charleson, S.; Denis, D.; Foster, A.; Fortin, R.; Leger, S.; McFarlane, C. S.; Morton, H.; Piechuta, H.; Riendeau, D.; Rouzer, C. A.; Rokach, J.; Young, R. (1989-05-01). "L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor". Canadian Journal of Physiology and Pharmacology. 67 (5): 456–464. doi:10.1139/y89-073. ISSN 0008-4212. PMID 2548691.